Reduced Radiation Fluoroscopy for Overactive Bladder
What You Need to Know Before You Apply
What is the purpose of this trial?
Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is reduced radiation fluoroscopy safe for humans?
Research shows that pulsed fluoroscopy, a type of reduced radiation fluoroscopy, generally lowers radiation exposure compared to conventional methods. This reduction in radiation has been observed in various medical procedures, suggesting it is a safer option for reducing radiation risks in humans.12345
How does reduced radiation fluoroscopy differ from other treatments for overactive bladder?
Reduced radiation fluoroscopy is unique because it uses a lower dose of radiation compared to conventional fluoroscopy, making it safer for patients by minimizing their exposure to radiation. This approach is particularly beneficial in procedures where fluoroscopy is needed, as it adheres to the principle of keeping radiation 'As Low As Reasonably Achievable' (ALARA).12367
What data supports the effectiveness of the treatment Reduced Radiation Fluoroscopy for Overactive Bladder?
Who Is on the Research Team?
Forrest Jellison, MD
Principal Investigator
Loma Linda University
Are You a Good Fit for This Trial?
This trial is for patients getting a sacral neuromodulation implant due to overactive bladder, which includes symptoms like urinary urgency, frequent urination at night, and possibly urge incontinence. It's not open to those with neurogenic bladder issues, a BMI over 40, or peripheral neuropathy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo sacral neuromodulation lead placement with either reduced or conventional fluoroscopy settings
Follow-up
Participants are monitored for safety and effectiveness after treatment, including a voiding log
What Are the Treatments Tested in This Trial?
Interventions
- Conventional fluoroscopy
- Reduced radiation fluoroscopy
Conventional fluoroscopy is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Diagnostic imaging
- Orthopedic procedures
- Cardiac catheterization
- Gastrointestinal examinations
- Diagnostic imaging
- Orthopedic procedures
- Cardiac catheterization
- Gastrointestinal examinations
- Sacral neuromodulation lead placement
- Diagnostic imaging
- Orthopedic procedures
- Cardiac catheterization
- Gastrointestinal examinations
- Diagnostic imaging
- Orthopedic procedures
- Cardiac catheterization
- Gastrointestinal examinations
- Diagnostic imaging
- Orthopedic procedures
- Cardiac catheterization
- Gastrointestinal examinations
- Diagnostic imaging
- Orthopedic procedures
- Cardiac catheterization
- Gastrointestinal examinations
Find a Clinic Near You
Who Is Running the Clinical Trial?
Loma Linda University
Lead Sponsor